Number of Disaggregated unit cost units of Setting in Proportion resource which Provider of of patients per relevant MBS/PBS Private resource Safety resource receiving time horizon Schedule govt health Patient is netsa cost resource per patient Fee budget insurer provided receiving resource $261.65 Twelve-lead Outpatient Number of Cost/ TBD electro- procedures/ procedure cardiography patient MBS item number $146.35 Resources provided in association with proposed intervention: associated with treating adverse events (other than cardiac monitoring) for patients receiving trastuzumab Will depend on TBD adverse events associated with trastuzumab usage Resources provided to deliver CF in clinical practice: Cisplatin Medical Outpatient/ % of No of vials/ Cost/vial TBD 10mg vial oncologist inpatient patients on patientc $11.35 doublet 100mg vial $39.78 chemo- 5-fluorouracil Outpatient/ TBD therapy 1000mg vial inpatient $48.22 (CF) 500mg vial $54.80 30% total OR Cost/pack pop’n Capecitabine (based on 150mg tablet $123.93 clinical 500mg tablet $695.17 advice) Chemotherapy administration costs (CF) Drug Medical % to be Number of Cost/ TBD administration cost oncologist Day patient based on infusions/ infusion for 1 to 6 hour health patientd infusion. an service MBS item outpatient setting usage data number or clinical 13918 opinion $94.20 Full day hospital % to be Number of Cost/ TBD admission for Day patient based on infusions/ infusion chemotherapy in a health patientd public hospital service TBD setting (excluding usage data average pharmacy or clinical cost component) opinion Full day hospital Day patient % to be Number of Cost/ TBD admission for on infusions/ infusion chemotherapy in a health patientd private hospital service TBD setting (excluding usage data average pharmacy or clinical cost component) opinion Resources provided to deliver ECF in clinical practice: Epirubicin Medical Outpatient/ % of No of vials/ Cost/vial TBD oncologist inpatient patients on patientc 10mg vial triplet $176.30 20mg vial chemo- $322.50
Provider of resource Setting in which resource is provided Proportion of patients receiving resource Number of units of resource per relevant time horizon per patient receiving resource Disaggregated unit cost MBS/PBS Schedule Fee Safety netsa govt budget Private health insurer Patient cost $261.65 Twelve-lead electro- cardiography Outpatient Number of procedures/ patient Cost/ procedure MBS item number TBD $146.35 Resources provided in association with proposed intervention: associated with treating adverse events (other than cardiac monitoring) for patients receiving trastuzumab Will depend on adverse events associated with trastuzumab usage TBD Resources provided to deliver CF in clinical practice: Cisplatin 10mg vial 100mg vial Medical oncologist Outpatient/ inpatient % of patients on doublet chemo- therapy (CF) 30% total pop’n (based on clinical advice) No of vials/ patientc Cost/vial $11.35 TBD $39.78 5-fluorouracil 1000mg vial 500mg vial OR Capecitabine 150mg tablet 500mg tablet Outpatient/ inpatient $48.22 TBD $54.80 Cost/pack $123.93 $695.17 Chemotherapy administration costs (CF) Drug administration cost for 1 to 6 hour infusion. an outpatient setting Medical oncologist Day patient % to be based on health service usage data or clinical opinion Number of infusions/ patientd Cost/ infusion MBS item number 13918 $94.20 TBD Full day hospital admission for chemotherapy in a public hospital setting (excluding average pharmacy cost component) Day patient % to be based on health service usage data or clinical opinion Number of infusions/ patientd Cost/ infusion TBD TBD Full day hospital admission for chemotherapy in a private hospital setting (excluding average pharmacy cost component) Day patient % to be on health service usage data or clinical opinion Number of infusions/ patientd Cost/ infusion TBD TBD Resources provided to deliver ECF in clinical practice: Epirubicin 10mg vial 20mg vial Medical oncologist Outpatient/ inpatient % of patients on triplet chemo- No of vials/ patientc Cost/vial $176.30 $322.50 TBD
1163-Final-Consultation-DAP-25-7-11-Accessible.docx